MOLECULAR SUBTYPES IN MUSCLE INVASIVE BLADDER CANCER: EVALUATION OF CLINICAL SIGNIFICANCE

被引:0
作者
Belew, Daniel
Morera, Daley
Lahorewala, Sarrah
Jordan, Andre
Klaassen, Zachary
Terris, Martha
Soloway, Mark
Lokeshwar, Vinata
机构
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
MP58-01
引用
收藏
页码:E772 / E773
页数:2
相关论文
共 50 条
[41]   Impact of consensus molecular subtypes on survival with and without adjuvant chemotherapy in muscle-invasive urothelial bladder cancer [J].
Koll, Florestan J. ;
Doering, Claudia ;
Herwig, Leon ;
Hoeh, Benedikt ;
Wenzel, Mike ;
Garcia, Cristina Cano ;
Banek, Severine ;
Kluth, Luis ;
Koellermann, Jens ;
Weigert, Andreas ;
Chun, Felix K-H ;
Wild, Peter ;
Reis, Henning .
JOURNAL OF CLINICAL PATHOLOGY, 2025, 78 (01) :19-27
[42]   Molecular Subtypes of Bladder Cancer [J].
David J. McConkey ;
Woonyoung Choi .
Current Oncology Reports, 2018, 20
[43]   Molecular Subtypes of Bladder Cancer [J].
McConkey, David J. ;
Choi, Woonyoung .
CURRENT ONCOLOGY REPORTS, 2018, 20 (10)
[44]   Prognostic value of novel immune basal subtypes in muscle invasive bladder cancer [J].
Choi, Woonyoung ;
Sundi, Debasish ;
Lee, I-ling ;
Siefker-Radtke, Arlene ;
Dinney, Colin ;
Czerniak, Bogdan ;
Kim, Seungchan ;
McConkey, David .
CANCER RESEARCH, 2019, 79 (13)
[45]   Molecular Subtypes of Bladder Cancer: Academic Exercise or Clinical Relevance? [J].
Dyrskjot, Lars .
EUROPEAN UROLOGY, 2019, 75 (03) :433-434
[46]   Prevention of local symptoms in muscle invasive bladder cancer patients: clinical significance of local radiation therapy [J].
Manabu Okada ;
Tetsuya Shindo ;
Keiko Fujino ;
Toshihiro Maeda ;
Naoki Ito ;
Atsushi Takahashi ;
Hiroshi Hotta ;
Yasuharu Kunishima ;
Masanori Matsukawa ;
Akio Takayanagi ;
Atsushi Wanifuchi ;
Seisuke Nofuji ;
Ryuichi Kato ;
Fumimasa Fukuta ;
Kohei Hashimoto ;
Ko Kobayashi ;
Toshiaki Tanaka ;
Naoya Masumori .
Supportive Care in Cancer, 2023, 31
[47]   Clinical significance of renin-angiotensin system inhibition on non-muscle invasive bladder cancer [J].
Downs, Tracy M. ;
Blute, Michael L., Jr. ;
Rushmer, Timothy J. ;
Shi, Fangfang ;
Fuller, Benjamin ;
Abel, E. Jason ;
Jarrard, David F. .
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2015, 221 (04) :E38-E38
[48]   Prevention of local symptoms in muscle invasive bladder cancer patients: clinical significance of local radiation therapy [J].
Okada, Manabu ;
Shindo, Tetsuya ;
Fujino, Keiko ;
Maeda, Toshihiro ;
Ito, Naoki ;
Takahashi, Atsushi ;
Hotta, Hiroshi ;
Kunishima, Yasuharu ;
Matsukawa, Masanori ;
Takayanagi, Akio ;
Wanifuchi, Atsushi ;
Nofuji, Seisuke ;
Kato, Ryuichi ;
Fukuta, Fumimasa ;
Hashimoto, Kohei ;
Kobayashi, Ko ;
Tanaka, Toshiaki ;
Masumori, Naoya .
SUPPORTIVE CARE IN CANCER, 2023, 31 (10)
[49]   Clinical Significance of Heme Oxygenase-1 Expression in Non-Muscle-Invasive Bladder Cancer [J].
Miyake, Makito ;
Fujimoto, Kiyohide ;
Anai, Satoshi ;
Ohnishi, Sayuri ;
Nakai, Yasushi ;
Inoue, Takeshi ;
Matsumura, Yoshiaki ;
Tomioka, Atsushi ;
Ikeda, Tomohiro ;
Tanaka, Nobumichi ;
Hirao, Yoshihiko .
UROLOGIA INTERNATIONALIS, 2010, 85 (03) :355-363
[50]   Molecular biomarkers in bladder preservation therapy for muscle-invasive bladder cancer [J].
Miyamoto, David T. ;
Mouw, Kent W. ;
Feng, Felix Y. ;
Shipley, William U. ;
Efstathiou, Jason A. .
LANCET ONCOLOGY, 2018, 19 (12) :E683-E695